Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

NELFINAVIR for Hepatitis c: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 10 adverse event reports in the FDA FAERS database where NELFINAVIR was used for Hepatitis c.

Most Reported Side Effects for NELFINAVIR

Side Effect Reports % Deaths Hosp.
Foetal exposure during pregnancy 290 24.9% 4 48
Drug resistance 117 10.1% 10 7
Lipodystrophy acquired 112 9.6% 1 1
Virologic failure 111 9.5% 7 8
Viral mutation identified 104 8.9% 2 0
Eyelid ptosis 88 7.6% 0 0
Pathogen resistance 87 7.5% 0 0
Mitochondrial toxicity 86 7.4% 0 1
Diplopia 83 7.1% 0 0
Progressive external ophthalmoplegia 73 6.3% 0 0
Treatment failure 69 5.9% 14 0
Maternal exposure during pregnancy 55 4.7% 0 12
Pregnancy 49 4.2% 2 7
Premature baby 48 4.1% 1 13
Treatment noncompliance 48 4.1% 1 7

Other Indications for NELFINAVIR

Hiv infection (708) Product used for unknown indication (200) Antiretroviral therapy (56) Hiv test positive (18) Prophylaxis against hiv infection (17) Plasma cell myeloma (12) Pancreatic carcinoma (11) Perinatal hiv infection (11) Acquired immunodeficiency syndrome (10) Chronic hepatitis c (9)

Other Drugs Used for Hepatitis c

RIBAVIRIN (20,657) PEGINTERFERON ALFA-2A (10,970) LEDIPASVIR\SOFOSBUVIR (8,924) DASABUVIR\OMBITASVIR\PARITAPREVIR\RITONAVIR (8,264) SOFOSBUVIR (7,691) SOFOSBUVIR\VELPATASVIR (4,956) GLECAPREVIR\PIBRENTASVIR (4,016) OMBITASVIR\PARITAPREVIR\RITONAVIR (2,906) TELAPREVIR (2,604) DASABUVIR (2,603)

Related Pages

NELFINAVIR Full Profile All Hepatitis c Drugs NELFINAVIR Demographics NELFINAVIR Timeline